Therapeutic, Prophylactic and Diagnostic Agents for Hepatitis B
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Nov 15, 2007
app pub date -
May 19, 2005
filing date -
May 19, 2004
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The present invention provides regulation of expression of toll-like receptors by the hepatitis B (HBV) pre-core protein, or its extracellular expression product the hepatitis B E antigen (HbeAg). Compounds regulating such expression have use in the treatment and prophylaxis of HBV infection in animal. The invention also provides methods for diagnosing HBV and agents useful in diagnostic protocols. The present invention further contemplates methods for monitoring disease states in humans and other animal species, including animal models, and providing an indication of the subject for infection by HBV, or development of other diseased states.
First Claim
Other Claims data not available